Sichuan Gangtong Medical Equipment Group Co., Ltd (SHE:301515)
China
· Delayed Price · Currency is CNY 19.63
+0.27 (1.39%)
At close: Jun 3, 2025, 2:57 PM CST
SHE:301515 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Operating Revenue | 754.06 | 840.43 | 766.2 | 678.2 | 561.34 |
| Other Revenue | - | 2.01 | 2.33 | 3.22 | 1.16 |
| Revenue | 754.06 | 842.44 | 768.53 | 681.41 | 562.49 |
| Revenue Growth (YoY) | -10.49% | 9.62% | 12.78% | 21.14% | - |
| Cost of Revenue | 604.23 | 614.04 | 546.74 | 496.67 | 389.27 |
| Gross Profit | 149.83 | 228.4 | 221.79 | 184.75 | 173.22 |
| Selling, General & Admin | 71.78 | 89.99 | 76.2 | 69.34 | 67.57 |
| Research & Development | 24.25 | 29.87 | 26.47 | 22.35 | 17.24 |
| Other Operating Expenses | -2.64 | 5.83 | 4.48 | 3.06 | 2.77 |
| Operating Expenses | 93.39 | 162.08 | 139.28 | 108.18 | 98.86 |
| Operating Income | 56.44 | 66.32 | 82.51 | 76.57 | 74.36 |
| Interest Expense | - | -4.2 | -4.78 | -4.42 | -3.54 |
| Interest & Investment Income | - | 6.34 | 0.99 | 1.46 | 1.25 |
| Currency Exchange Gain (Loss) | - | 0.01 | 0.05 | -0.01 | -0.58 |
| Other Non Operating Income (Expenses) | -41.73 | -0.51 | 0.93 | 0.75 | -1.76 |
| EBT Excluding Unusual Items | 14.71 | 67.96 | 79.69 | 74.34 | 69.72 |
| Gain (Loss) on Sale of Investments | 0.96 | - | - | - | - |
| Gain (Loss) on Sale of Assets | 0.08 | 17.82 | -0.02 | - | - |
| Asset Writedown | -0.64 | 0.03 | -0.03 | -0.1 | -0.69 |
| Legal Settlements | - | -0.08 | -0.27 | -0.22 | -0.77 |
| Other Unusual Items | - | 9.14 | 3.93 | 7.59 | 7.67 |
| Pretax Income | 15.1 | 94.87 | 83.3 | 81.61 | 75.94 |
| Income Tax Expense | 0.68 | 11.77 | 9.37 | 9.93 | 10.65 |
| Net Income | 14.42 | 83.1 | 73.93 | 71.68 | 65.29 |
| Net Income to Common | 14.42 | 83.1 | 73.93 | 71.68 | 65.29 |
| Net Income Growth | -82.64% | 12.40% | 3.14% | 9.79% | - |
| Shares Outstanding (Basic) | 99 | 85 | 75 | 75 | 75 |
| Shares Outstanding (Diluted) | 99 | 85 | 75 | 75 | 75 |
| Shares Change (YoY) | 16.20% | 13.89% | -0.00% | 0.00% | - |
| EPS (Basic) | 0.15 | 0.97 | 0.99 | 0.96 | 0.87 |
| EPS (Diluted) | 0.15 | 0.97 | 0.99 | 0.96 | 0.87 |
| EPS Growth | -85.06% | -1.31% | 3.14% | 9.79% | - |
| Free Cash Flow | -47.94 | -143.06 | 42.88 | 8.81 | 46.66 |
| Free Cash Flow Per Share | -0.48 | -1.68 | 0.57 | 0.12 | 0.62 |
| Dividend Per Share | - | 0.258 | - | - | - |
| Gross Margin | 19.87% | 27.11% | 28.86% | 27.11% | 30.80% |
| Operating Margin | 7.49% | 7.87% | 10.74% | 11.24% | 13.22% |
| Profit Margin | 1.91% | 9.86% | 9.62% | 10.52% | 11.61% |
| Free Cash Flow Margin | -6.36% | -16.98% | 5.58% | 1.29% | 8.29% |
| EBITDA | 62.36 | 71.96 | 88.81 | 83.01 | 80.57 |
| EBITDA Margin | 8.27% | 8.54% | 11.56% | 12.18% | 14.32% |
| D&A For EBITDA | 5.91 | 5.65 | 6.3 | 6.45 | 6.21 |
| EBIT | 56.44 | 66.32 | 82.51 | 76.57 | 74.36 |
| EBIT Margin | 7.49% | 7.87% | 10.74% | 11.24% | 13.22% |
| Effective Tax Rate | 4.50% | 12.41% | 11.25% | 12.17% | 14.02% |
| Revenue as Reported | - | 842.44 | 768.53 | 681.41 | 562.49 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.